HomeDNTH • NASDAQ
add
Dianthus Therapeutics Inc
Previous close
$44.71
Day range
$43.61 - $45.08
Year range
$13.37 - $45.46
Market cap
1.90B USD
Avg Volume
689.11K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 396.00K | -81.77% |
Operating expense | 40.68M | 26.85% |
Net income | -36.76M | -46.04% |
Net profit margin | -9.28K | -701.03% |
Earnings per share | -0.97 | — |
EBITDA | -40.26M | -34.76% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 402.61M | 43.22% |
Total assets | 577.44M | 63.01% |
Total liabilities | 30.99M | 89.55% |
Total equity | 546.45M | — |
Shares outstanding | 42.88M | — |
Price to book | 3.51 | — |
Return on assets | -22.29% | — |
Return on capital | -23.64% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -36.76M | -46.04% |
Cash from operations | -30.56M | -43.67% |
Cash from investing | -201.28M | 22.40% |
Cash from financing | 274.51M | 92,640.88% |
Net change in cash | 42.68M | 115.23% |
Free cash flow | -20.53M | -97.51% |
About
Founded
2019
Website
Employees
78
